Mail

UK markets closed

FTSE 100
8,213.49
+41.34(+0.51%)
FTSE 250
20,164.54
+112.21(+0.56%)
AIM
771.53
+3.42(+0.45%)
GBP/EUR
1.1652
-0.0031(-0.26%)
GBP/USD
1.2546
+0.0013(+0.11%)
Bitcoin GBP
50,209.74
+2,977.80(+6.30%)

Best savings accounts that offer above inflation rates

Where to find a top-rated deal that works for you

Ekso Bionics Holdings, Inc. (EKSO)

NasdaqCM - NasdaqCM Real-time price. Currency in USD

Add to watchlist

1.3100

+0.0200

(+1.55%)

At close: 04:00PM EDT

Currency in USD

Valuation measures⁴

Market cap (intra-day)	23.81M
Enterprise value	21.85M
Trailing P/E	N/A
Forward P/E	N/A
PEG ratio (5-yr expected)	N/A
Price/sales (ttm)	1.09
Price/book (mrq)	1.69
Enterprise value/revenue	1.20
Enterprise value/EBITDA	-1.66

Trading information

Stock price history

Beta (5Y monthly)	1.64
52-week change ³	-17.83%
S&P500 52-week change ³	22.38%
52-week high ³	3.1290
52-week low ³	0.6200
50-day moving average ³	1.4617
200-day moving average ³	1.4041

Share statistics

Avg vol (3-month) ³	147.74k
Avg vol (10-day) ³	72.01k
Shares outstanding ⁵	18.17M
Implied shares outstanding ⁶	18.17M
Float ⁸	15.59M
% held by insiders ¹	13.30%
% held by institutions ¹	7.49%
Shares short (15 Apr 2024) ⁴	190.33k
Short ratio (15 Apr 2024) ⁴	1.72
Short % of float (15 Apr 2024) ⁴	1.10%
Short % of shares outstanding (15 Apr 2024) ⁴	1.06%
Shares short (prior month 15 Mar 2024) ⁴	111.22k

Dividends & splits

Forward annual dividend rate ⁴	N/A
Forward annual dividend yield ⁴	N/A
Trailing annual dividend rate ³	0.00
Trailing annual dividend yield ³	0.00%
5-year average dividend yield ⁴	N/A
Payout ratio ⁴	0.00%
Dividend date ³	25 Mar 2020
Ex-dividend date ⁴	N/A
Last split factor ²	1:15
Last split date ³	25 Mar 2020

Financial highlights

Fiscal year

Fiscal year ends	31 Dec 2023
Most-recent quarter (mrq)	31 Mar 2024

Profitability

Profit margin	-19.80%
Operating margin (ttm)	-86.69%

Management effectiveness

Return on assets (ttm)	-26.34%
Return on equity (ttm)	-20.08%

Income statement

Revenue (ttm)	17.91M
Revenue per share (ttm)	1.20
Quarterly revenue growth (yoy)	-8.90%
Gross profit (ttm)	N/A
EBITDA	-12.21M
Net income avi to common (ttm)	-3.55M
Diluted EPS (ttm)	-0.9700
Quarterly earnings growth (yoy)	N/A

Balance sheet

Total cash (mrq)	8.8M
Total cash per share (mrq)	0.5
Total debt (mrq)	6.84M
Total debt/equity (mrq)	48.69%
Current ratio (mrq)	2.81
Book value per share (mrq)	0.81

Cash flow statement

Operating cash flow (ttm)	N/A
Levered free cash flow (ttm)	N/A